Comparison of HPV testing and cervical cytology in prevention of cervical cancer
DOI:
https://doi.org/10.12775/JEHS.2022.12.08.077Keywords
cervical cancer, cervical screening, cytology, HPV primary screening, HPV testingAbstract
Introduction and purpose
This article aims to compare two guiding methods of cervical cancer screening: cervical cytology
and HPV testing. The objective is to provide information on which method
is currently more relevant in the early detection of precancerous lesions and and therefore should
be more frequently used.
Materials and method
This review was mainly based on articles from around the world collected in Pubmed in 2003-2022, medical books and websites. The research was done by looking through keywords as follows: “cervical cancer”, “cytology”, “HPV testing”.
Results
All selected studies have demonstrated that HPV testing is a more appropriate indicator for initial high-grade CIN (cervical intraepithelial neoplasia) than cytology.
Conclusions
According to the cited researches, the public health system should definitely pay more attention
to HPV testing as the first stage of cervical cancer screening. Moreover,
it should clarify by comparing all advantages and disadvantages of methods, which further diagnostic pathway is the most effective and has the best outcomes for the patients.
Keywords
cervical cancer, cervical screening, cytology, HPV primary screening, HPV testing
References
Stec R, Deptała A, Smoter M. Onkologia – pomoc dydaktyczna dla studentów
i lekarzy specjalizujących się w onkologii. Wydawnictwo AsteriaMed Gdańsk 2019 Wyd.1.
Bręborowicz GH, Rechberger T. (red.): Ginekologia, tom 2, Warszawa 2020, PZWL Wydawnictwo Lekarskie.
Chan KKL, Liu SS, Wei N, Ngu SF, Chu MMY, Tse KY, Lau LSK, Cheung ANY, Ngan HYS. Primary HPV testing with cytology versus cytology alone in cervical screening-A prospective randomized controlled trial with two rounds of screening in a Chinese population. Int J Cancer. 2020 Aug 15;147(4):1152-1162. doi: 10.1002/ijc.32861. Epub 2020 Jan 24. PMID: 31922265.
Didkowska J, Wojciechowska U, Czaderny K, Olasek P, Ciuba A. Cancer in Poland in 2017. Polish National Cancer Registry 2019; Department of Epidemiology and Cancer Prevention, p. 1–35.
Zarankiewicz, N., Zielińska, M., Kosz, K., Kuchnicka, A., and Ciseł, B. (2020). High-risk HPV test in cervical cancer prevention – present and future. J Pre Clin Clin Res., 14(3), pp.80-84. https://doi.org/10.26444/jpccr/126432.
Koliopoulos G, Nyaga VN, Santesso N, Bryant A, Martin-Hirsch PP, Mustafa RA, Schünemann H, Paraskevaidis E, Arbyn M. Cytology versus HPV testing for cervical cancer screening in the general population. Cochrane Database Syst Rev. 2017 Aug 10;8(8):CD008587. doi: 10.1002/14651858.CD008587.pub2. PMID: 28796882; PMCID: PMC6483676.
Thomsen LT, Kjær SK, Munk C, Frederiksen K, Ørnskov D, Waldstrøm M. Clinical Performance of Human Papillomavirus (HPV) Testing versus Cytology for Cervical Cancer Screening: Results of a Large Danish Implementation Study. Clin Epidemiol. 2020 Feb 21;12:203-213. doi: 10.2147/CLEP.S243546. PMID: 32110112; PMCID: PMC7041597.
https://dziennikustaw.gov.pl/DU/2005/s/143/1200 (access: 21.08.2022)
www.gov.pl/web/zdrowie/program-profilaktyki-raka-szyjki-macicy (access 21.08.2022).
Jankowska P, Kikolska M, Kwiatkowska M, Kochman D, Głowacka M. The level of knowledge on cervical cancer among women. Innowacje Piel Nauk Zdr. 2017; 1: 22–46.
https://en.wikipedia.org/wiki/Georgios_Papanikolaou (access 21/08/2022)
https://en.wikipedia.org/wiki/Aurel_Babe%C8%99 (access 21/08/2022)
Davey E, d'Assuncao J, Irwig L, Macaskill P, Chan SF, Richards A, Farnsworth A. Accuracy of reading liquid based cytology slides using the ThinPrep Imager compared with conventional cytology: prospective study. BMJ. 2007 Jul 7;335(7609):31. doi: 10.1136/bmj.39219.645475.55. Epub 2007 Jun 29. PMID: 17604301; PMCID: PMC1910624.
Denton KJ. Liquid based cytology in cervical cancer screening. BMJ. 2007 Jul 7;335(7609):1-2. doi: 10.1136/bmj.39262.506528.47. PMID: 17615183; PMCID: PMC1910620.
Ronco G, Cuzick J, Pierotti P, Cariaggi MP, Dalla Palma P, Naldoni C, Ghiringhello B, Giorgi-Rossi P, Minucci D, Parisio F, Pojer A, Schiboni ML, Sintoni C, Zorzi M, Segnan N, Confortini M. Accuracy of liquid based versus conventional cytology: overall results of new technologies for cervical cancer screening: randomised controlled trial. BMJ. 2007 Jul 7;335(7609):28. doi: 10.1136/bmj.39196.740995.BE. Epub 2007 May 21. PMID: 17517761; PMCID: PMC1910655.
Demarco M, Carter-Pokras O, Hyun N, Castle PE, He X, Dallal CM, et al. Validation of a Human Papillomavirus (HPV) DNA Cervical Screening Test That Provides Expanded HPV Typing. J Clin Microbiol. 2018; 56(5): 01910–17. doi: 10.1128/JCM.01910-17.
Wright TC, Stoler MH, Behrens CM, Sharma A, Zhang G, Wright TL. Primary cervical cancer screening with human papillomavirus: end of study results from the ATHENA study using HPV as the first-line screening test. Gynecol Oncol. 2015 Feb;136(2):189-97. doi: 10.1016/j.ygyno.2014.11.076. Epub 2015 Jan 8. PMID: 25579108.
Racey CS, Withrow DR, Gesink D. Self-collected HPV testing improves participation in cervical cancer screening: a systematic review and meta-analysis. Can J Public Health. 2013 Feb 11;104(2):e159-66. doi: 10.1007/BF03405681. PMID: 23618210; PMCID: PMC6973997.
Bansil P, Wittet S, Lim JL, Winkler JL, Paul P, Jeronimo J. Acceptability of self-collection sampling for HPV-DNA testing in low-resource settings: a mixed methods approach. BMC Public Health. 2014 Jun 12;14:596. doi: 10.1186/1471-2458-14-596. PMID: 24927941; PMCID: PMC4061776.
Thomsen LT, Kjaer SK, Munk C, Ørnskov D, Waldstrøm M. Benefits and potential harms of human papillomavirus (HPV)-based cervical cancer screening: A real-world comparison of HPV testing versus cytology. Acta Obstet Gynecol Scand. 2021 Mar;100(3):394-402. doi: 10.1111/aogs.14121. Epub 2021 Mar 14. PMID: 33566361.
Lew JB, Simms KT, Smith MA, Hall M, Kang YJ, Xu XM, Caruana M, Velentzis LS, Bessell T, Saville M, Hammond I, Canfell K. Primary HPV testing versus cytology-based cervical screening in women in Australia vaccinated for HPV and unvaccinated: effectiveness and economic assessment for the National Cervical Screening Program. Lancet Public Health. 2017 Feb;2(2):e96-e107. doi: 10.1016/S2468-2667(17)30007-5. Epub 2017 Feb 7. PMID: 29253402.
C Kitchener H, Canfell K, Gilham C, Sargent A, Roberts C, Desai M, Peto J. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomiSed trial cohort through three screening rounds. Health Technol Assess. 2014 Apr;18(23):1-196. doi: 10.3310/hta18230. PMID: 24762804; PMCID: PMC4781243.
Lörincz AT, Richart RM. Human papillomavirus DNA testing as an adjunct to cytology in cervical screening programs. Arch Pathol Lab Med. 2003 Aug;127(8):959-68. doi: 10.5858/2003-127-959-HPDTAA. PMID: 12873167.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Klaudia Remjasz, Katarzyna Kosz, Aleksandra Kuchnicka, Julia Kuchnicka, Jakub Aleksandrowicz, Martyna Zielińska, Natalia Zarankiewicz, Wojciech Siedlecki, Klaudia Sapuła
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 708
Number of citations: 0
